End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
2.66 EGP | -7.96% | +0.76% | -15.29% |
Mar. 03 | Ibnsina Pharma Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
Feb. 05 | Ibnsina Pharma(CASE:ISPH) added to EGX 30 Index | CI |
Sales 2024 * | 36.64B 759M | Sales 2025 * | 44.09B 913M | Capitalization | 2.68B 55.54M |
---|---|---|---|---|---|
Net income 2024 * | 417M 8.64M | Net income 2025 * | 417M 8.64M | EV / Sales 2024 * | 0.17 x |
Net Debt 2024 * | 3.65B 75.58M | Net Debt 2025 * | 3.56B 73.77M | EV / Sales 2025 * | 0.14 x |
P/E ratio 2024 * |
8.87
x | P/E ratio 2025 * |
6.91
x | Employees | 5,500 |
Yield 2024 * |
1.47% | Yield 2025 * |
2.91% | Free-Float | 61.4% |
1 day | -7.96% | ||
1 week | +0.76% | ||
Current month | +11.30% | ||
1 month | +1.92% | ||
3 months | -21.76% | ||
6 months | +27.15% | ||
Current year | -15.29% |
Managers | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | - | 00-12-17 | |
Chief Executive Officer | - | 00-12-17 | |
Momen Gomaa
DFI | Director of Finance/CFO | - | - |
Members of the board | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | - | 00-12-17 | |
Chief Executive Officer | - | 00-12-17 | |
Director/Board Member | - | - |
Date | Price | Change | Volume |
---|---|---|---|
24-04-18 | 2.66 | -7.96% | 12,810,700 |
24-04-17 | 2.89 | +2.48% | 15,640,140 |
24-04-16 | 2.82 | +0.36% | 9,879,665 |
End-of-day quote Egyptian Exchange, April 17, 2024
More quotesEPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-15.29% | 55.48M | |
-30.14% | 15.74B | |
-41.56% | 9.3B | |
-10.75% | 6.02B | |
+6.59% | 5.96B | |
-38.44% | 5.36B | |
+2.34% | 4.86B | |
+50.00% | 4.22B | |
-12.78% | 3.57B | |
-10.36% | 3.51B |
- Stock Market
- Equities
- ISPH Stock